Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and pharmacodynamics of subcutaneous insulin aspart via FlexPen compared to inhaled insulin (Exubera)
2007-002060-10Phase 3Completed
- Sponsor
- IKFE
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of insulin aspart and Technosphere insulin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM) and diabetes mellitus (DM) (2 arms), sponsored by IKFE. Primary endpoints: Pharmacokinetics and Pharmacodynamics. Started May 2007; status: completed.
02
Drugs
insulin aspartTechnosphere insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)diabetes mellitus (DM)
Beyond the preview
Go deeper on 2007-002060-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002060-10.